Introduction. When introducing new joint replacement designs, it is difficult to predict with any certainty the clinical performance of the new designs. Using roentgen stereophotogrammetric analysis (RSA) to evaluate the first two years of follow-up can serve as a predictor of late mechanical loosening for hip and knee prostheses. This prospectively randomized study was designed to evaluate the clinical performance of the Triathlon total knee system and compare the results between the two versions; posterior stabilized (PS) and cruciate retaining (CR). Methods. Sixty patients were consecutively randomized (two patients left the study prior to surgery) to receive either the Triathlon total knee PS (30 patients) or the Triathlon total knee CR (28 patients). All components were cemented. The study was approved by the Ethical Committee for Lund University. All patients met the inclusion criteria. There were no statistically significant differences between the demographics for PS and CR. RSA was set to be the principal evaluation parameter. Patient outcome was assessed by the KSS and KOOS questionnaires. Results. There were no statistically significant differences in rotation or translation around or along the three coordinal axes. Neither were there any differences in the maximal total point motion (MTPM) during the 2-year follow-up (p<0.05). There were no statistically significant differences between the clinical results of both groups when using the KSS and the KOOS scoring system (p<0.05). Discussion. There were no clinically significant differences in the RSA 2-year follow-up data, nor in the clinical scores of KSS and KOOS. The results of this study suggest that there is no major differences between the posterior stabilized system and the cruciate retaining system for the Triathlon total knee neither in clinical nor in predictable long term mechanical performance

Patients with transfemoral amputation (TFA) often experience problems related to the use of socket-suspended prostheses. The clinical development of osseointegrated percutaneous prostheses for patients with a TFA started in 1990, based on the long-term successful results of osseointegrated dental implants.

Between1999 and 2007, 51 patients with 55 TFAs were consecutively enrolled in a prospective, single-centre non-randomised study and followed for two years. The indication for amputation was trauma in 33 patients (65%) and tumour in 12 (24%). A two-stage surgical procedure was used to introduce a percutaneous implant to which an external amputation prosthesis was attached. The assessment of outcome included the use of two self-report questionnaires, the Questionnaire for Persons with a Transfemoral Amputation (Q-TFA) and the Short-Form (SF)-36.

The cumulative survival at two years’ follow-up was 92%. The Q-TFA showed improved prosthetic use, mobility, global situation and fewer problems (all p < 0.001). The physical function SF-36 scores were also improved (p < 0.001). Superficial infection was the most frequent complication, occurring 41 times in 28 patients (rate of infection 54.9%). Most were treated effectively with oral antibiotics. The implant was removed in four patients because of loosening (three aseptic, one infection).

Osseointegrated percutaneous implants constitute a novel form of treatment for patients with TFA. The high cumulative survival rate at two years (92%) combined with enhanced prosthetic use and mobility, fewer problems and improved quality of life, supports the ‘revolutionary change’ that patients with TFA have reported following treatment with osseointegrated percutaneous prostheses.

Cite this article: Bone Joint J 2014;96-B:106–13.